BURNING ROCK BIOTECH LTD-ADR (BNR) Stock Price & Overview
NASDAQ:BNR • US12233L2060
The current stock price of BNR is 22.85 USD. Today BNR is down by -2.6%. In the past month the price decreased by -20.88%. In the past year, price increased by 283.39%.
BNR Key Statistics
- Market Cap
- 234.411M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.77
- Dividend Yield
- N/A
BNR Stock Performance
BNR Stock Chart
BNR Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to BNR. When comparing the yearly performance of all stocks, BNR is one of the better performing stocks in the market, outperforming 98.48% of all stocks.
BNR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNR. BNR may be in some trouble as it scores bad on both profitability and health.
BNR Earnings
BNR Forecast & Estimates
For the next year, analysts expect an EPS growth of -277.41% and a revenue growth 48.35% for BNR
BNR Groups
Sector & Classification
BNR Financial Highlights
Over the last trailing twelve months BNR reported a non-GAAP Earnings per Share(EPS) of -1.77. The EPS increased by 93.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -14.93% | ||
| ROE | -22.06% | ||
| Debt/Equity | 0 |
BNR Ownership
BNR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.19 | 402.577B | ||
| AMGN | AMGEN INC | 16.11 | 203.574B | ||
| GILD | GILEAD SCIENCES INC | 16.43 | 181.247B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.66 | 125.079B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.97 | 81.897B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.52 | 42.495B | ||
| INSM | INSMED INC | N/A | 30.048B | ||
| BIIB | BIOGEN INC | 11.5 | 27.955B | ||
| NTRA | NATERA INC | N/A | 27.865B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.84 | 23.875B | ||
| MRNA | MODERNA INC | N/A | 22.105B | ||
| EXAS | EXACT SCIENCES CORP | 339.75 | 19.738B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.736B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BNR
Company Profile
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Company Info
IPO: 2020-06-12
BURNING ROCK BIOTECH LTD-ADR
No. 5 Xingdao Ring Road North, International Bio Island
Guangzhou GUANGDONG 510005 CN
CEO: Yusheng Han
Employees: 674
Phone: 8618501641666
BURNING ROCK BIOTECH LTD-ADR / BNR FAQ
Can you describe the business of BURNING ROCK BIOTECH LTD-ADR?
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Can you provide the latest stock price for BURNING ROCK BIOTECH LTD-ADR?
The current stock price of BNR is 22.85 USD. The price decreased by -2.6% in the last trading session.
Does BNR stock pay dividends?
BNR does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNR stock?
BNR has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the employee count for BNR stock?
BURNING ROCK BIOTECH LTD-ADR (BNR) currently has 674 employees.
What is BURNING ROCK BIOTECH LTD-ADR worth?
BURNING ROCK BIOTECH LTD-ADR (BNR) has a market capitalization of 234.41M USD. This makes BNR a Micro Cap stock.
What is the ownership structure of BURNING ROCK BIOTECH LTD-ADR (BNR)?
You can find the ownership structure of BURNING ROCK BIOTECH LTD-ADR (BNR) on the Ownership tab.